Trial Profile
Evaluation of Lifestyle and Therapeutic Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Voglibose (Primary)
- Indications Coronary artery disease; Glucose intolerance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms EIIGETPCHD
- 19 Aug 2008 New trial record.